Available Technologies - Technology Categories

All Categories > Research Tools > Animal Models


 Tech ID   Title    
24151 Novel Therapeutic Targets in Liver Fibrosis Show Detail Description
24144 CD33 Null Mice: Murine Model for Alzheimer's Disease Show Detail Description
23900 Assay to Measure Synaptic Plasticity Show Detail Description
23726 Treatment Of Post-Partum Depression By Altering GABA Receptor Function Show Detail Description
23536 Construction Of A New Murine Model To Study The Contribution Of Complement And Complement-Mediated Inflammation In Human Diseases Show Detail Description
23469 Lhx2 Conditional Knockout Mouse ("Lhx2 Cko") Show Detail Description
23281 Crosslinking Strategy for Catheter Delivery of Injectable Hydrogels Show Detail Description
23032 Automated Scratch Detection System (Pruritis in Rodents) Show Detail Description
22995 A Genetic Model For Deoxycytidine Kinase Deficiency Show Detail Description
22805 Dual Transgenic Mice for Endothelial Cell Research (Ve-Cadherin Cre-Recombinase - Rosa26r-YFP) Show Detail Description
22747 Patient-derived, Murine Model of Prostate Cancer Show Detail Description
22586 Ras-Driven Conditional Model Of Liver Cancer Show Detail Description
22413 Collaboration Opportunity: Novel Mouse Models of Human Hepatitis B Virus Infection for Drug Discovery and Vaccine Research Show Detail Description
22407 Novel Imaging Technique Combines Optical and MR Imaging Systems To Obtain High Resolution Optical Images Show Detail Description
22293 Cloned Zebrafish from Long-Term Cultured Cells Show Detail Description
22264 mGFAP-Cre-Recombinase Transgenic Mouse Strains Show Detail Description
22199 Alzheimer's Disease Cellular Model for Diagnostic and Therapeutic Development Methods Show Detail Description
22100 A Monoclonal Antibody that Recognizes the Mouse RIN1 Protein Show Detail Description
22099 Polyclonal Antibody Recognizing the Human RIN2 Protein Show Detail Description
21942 JNK1 and JNK2 Deficient Mice Show Detail Description
21941 MLC2V-Cre Mice Show Detail Description
21938 IKK alpha -/-, IKK beta -/-, IKK gamma -/-, IKK Wild Type Cell Lines Show Detail Description
21937 Anti-Light Hybridoma Cell Line Show Detail Description
21935 IKKB LOX/LOX Show Detail Description
21933 Knockout Mice Deleting 2a Subunit of Sodium Channel Show Detail Description
21932 Knockout Mice Deleting Kinesin 3a Show Detail Description
21931 New Mice: Crossbred JNK1 KO/JNK2 KO Mice Show Detail Description
21928 IKKalpha +/- Mice Show Detail Description
21927 In-Vivo Propagated Murine A20 Lymphoma Cells Show Detail Description
21926 Expression of Human CYP1A1 in Mice Show Detail Description
21895 Targeted Intracellular Delivery of Nucleic Acids via Conjugation to Non-Lipid Carrier Molecules Show Detail Description
21775 Transgenic Mice for Testing and Screening Anti-Fibrotic Therapy Show Detail Description
21651 Wireless Lab-on-a-Chip for Cardiac Implants for the Continuous Analysis of Blood Flow Show Detail Description
21529 Rosa HD Show Detail Description
21519 Transgenic Mouse Model of Parkinson's Disease with Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Loss, And Alpha Synuclein Accumulation Show Detail Description
21512 A Humanized Mouse Model Of Severe Asthma Show Detail Description
21499 Male Mice Lacking Sry On The Y Chromosome With A Function Autosomal Sry Transgene Show Detail Description
21497 SYNAPTOTAGMIN-4 KNOCKOUT MICE Show Detail Description
21496 Ptgs2 (Cyclooxygenase-2) Conditional Knockout Mouse Show Detail Description
21495 Ptgs2 (Cyclooxygenase-2) Luciferase Knock-In Mouse Show Detail Description
21487 Bone Morphogenetic Protein Receptor type 1B (BMPR1B or Alk6) Knockout Mouse Show Detail Description
21484 VE-Cadherin-Cre-recombinase Transgenic Mouse Show Detail Description
21483 Floxed Mouse For Progesterone Receptor (PRCE) Show Detail Description
21482 VE-cadherin-CreERT2 Transgenic Mouse Show Detail Description
21466 Fox-1 Transgenic Mice Show Detail Description
21465 Fox-2 Transgenic Mice Show Detail Description
20535 Pituitary Adenylyl Cyclase-activating Peptide (PACAP) Deficient Mice Show Detail Description
20533 Use of a Gene and Related Mouse Model for the Study and Development of Therapeutics for Neuropsychiatric Disorders Show Detail Description
20532 C-myc Transgenic Mouse Show Detail Description
20525 Tcl1 Transgenic Mice Show Detail Description
20506 Novel Mouse Model for Huntingtons Disease Show Detail Description
20473 EPO Knockout, EPOR Knockout and EPOR Conditional Knockdown Mice Show Detail Description
20469 Mouse Model for Premature Aging: Zmpste24 Knockout Mice Show Detail Description
20413 Mouse Model for Conditional Knockout of the PTEN Gene Show Detail Description
20361 Gpat4 Knockout Mouse Show Detail Description
20321 Genetically Engineered Mice Lacking a Tumor Suppressor Gene in the CNS Show Detail Description
20294 Murine PTEN Null Prostate Cancer Model Show Detail Description
20279 B-raf/loxp-flanked Mutant Mouse Show Detail Description
20267 Inducible Dominant Negative Disc1 Transgenic Mice as a Model for Schizophrenia Show Detail Description
20190 Transgenic Mice with Prostate-specific Reporter Gene Expression Show Detail Description
20189 Adipose Tissue-specific PTEN Knockout Mice Show Detail Description
20141 Anti-MAGI-2 Rabbit Polyclonal Antibody Show Detail Description
20140 Mouse Model Deficient for the Proton Sensing Gpcr T-cell Death-associated Gene 8 (tdag) Show Detail Description
20139 Proton-sensing G Protein-coupled Receptor 4 Knockout Show Detail Description
20100 G2A GPCR Deficient Mouse Model and G2A Monoclonal Antibody Show Detail Description
20085 Myeloperoxidase-Deficient Mouse Show Detail Description
20075 A Human Inflammatory Breast Carcinoma Xenograft Model of the Intravasation Step of Metastasis Show Detail Description
20059 Vasoactive Intestinal Peptide (VIP) and Peptide Histidine Isoleucine (PHI) Knockout Mice Show Detail Description
19891 Mouse Models of Cryophrin Associated Periodic Syndromes Show Detail Description
19856 IKKBETA LOX/EE Mice Show Detail Description
19851 TNFalpha Knock-Out Mice Show Detail Description
19849 LysM-Cre/IKKBeta Flox Mice (Cre) Show Detail Description
19768 Floxed IKKB Mice Show Detail Description
19766 IKK Alpha (AA) Mice Show Detail Description
19752 IKK Beta Liver Knockout CRE Mice Show Detail Description
19750 Mice Lacking IKK Beta in Liver Cells—Models for Acute Hepatic Failure, Hepatocellular Carcinoma and Increased Sensitivity to Insulin Show Detail Description
19748 Mice Lacking IKKß in Macrophages Show Detail Description
19747 VILLIN-CRE/IKKBETA LOXLOX Mice Show Detail Description
19746 LYSM-CRE/IKKBETA LOXLOX Mice Show Detail Description
19735 High-Throughput Functional Evaluation of Mouse Phenotype Show Detail Description
19734 Animal Model to Detect the Presence of Environmental Toxicants Show Detail Description
19717 Automated Nociception Analyzer/Flinch Monitor Show Detail Description
19486 Mice Lacking Ikkß In Intestinal Epithelial Cells Show Detail Description
19191 Transgenic Mice Over-Expressing Caveolin-3 (M-Caveolin) within the Cardiac Myocyte Show Detail Description
19127 MOUSE MODEL OF OSTEOPOROSIS Show Detail Description
19104 MOUSE MODEL FOR STUDYING INTEGRIN B8 IMPORTANT IN DEVELOPMENT AND HOMOESTASIS: ITGB8 TRANSGENIC MICE Show Detail Description
19070 Mouse Model for Studying Epithelial Derived Tumors Show Detail Description
19032 A NEW TRANSGENIC MOUSE LINE TO STUDY ADULT NEUROGENESIS Show Detail Description
18956 Vectors and methods for high-throughput, site-specific genetic modification of mouse embryonic stem cells Show Detail Description
18907 A Drosophila Model Of Triplet Repeat Pathogenesis Show Detail Description
18891 Triple Transgenic Mouse Model of Alzheimer's Disease Show Detail Description
18844 Nrf1 Deficient Mice as a Model for Liver Cancer and Non-Alcoholic Steatohepatitis Show Detail Description
18834 Transgenic Mouse Model for Screening Analgesic Agents Show Detail Description
18829 New Non-toxic Compounds that Sensitize Cells for DNA Damage Agents and Serving as Adjuvants in Chemotherapy of Cancer Show Detail Description
18817 Methods and Compostions for the Treatment of Immune Disorders and Regulation of Cytokine and Growth Factor Signaling Show Detail Description
18801 Methods and Reagents for Screening New Drugs and Treating Ion Pump Associated Disorders Show Detail Description
18782 New Non-toxic Compounds that Sensitize Cells for DNA Damage Agents and Serving as Adjuvants in Chemotherapy of Cancer Show Detail Description
18776 Microfluidic Device for Forming Monodisperse Lipoplexes Show Detail Description
18765 A New Mouse Model of Sjogren's Syndrome Show Detail Description
17681 Optical Platform For The Study Of Neuron Networks And Other Complex Biological Systems Show Detail Description

Back To Search

University of California
Innovation Alliances and Services

1111 Franklin Street, 5th Floor, Oakland, CA 94607-5200 | http://www.ucop.edu/ott/
Tel: 510.587.6000 | Fax: 510.587.6090 | UC.technologies@ucop.edu